.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Moodys
Healthtrust
Fish and Richardson
Express Scripts
Citi
McKesson
Accenture
Merck
AstraZeneca

Generated: November 23, 2017

DrugPatentWatch Database Preview

DELALUTIN Drug Profile

« Back to Dashboard

What is the patent landscape for Delalutin, and what generic Delalutin alternatives are available?

Delalutin is a drug marketed by Bristol Myers Squibb and is included in two NDAs.

The generic ingredient in DELALUTIN is hydroxyprogesterone caproate. There are eleven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydroxyprogesterone caproate profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
DELALUTIN
hydroxyprogesterone caproate
INJECTABLE;INJECTION016911-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
DELALUTIN
hydroxyprogesterone caproate
INJECTABLE;INJECTION010347-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
DELALUTIN
hydroxyprogesterone caproate
INJECTABLE;INJECTION016911-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Bristol Myers Squibb
DELALUTIN
hydroxyprogesterone caproate
INJECTABLE;INJECTION010347-004Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Chubb
Teva
McKesson
Fuji
Merck
Cantor Fitzgerald
Cipla
Julphar
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot